Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid
2005

Using Singlet Oxygen Luminescence to Measure Photodynamic Therapy Effectiveness

Sample size: 39 publication Evidence: moderate

Author Information

Author(s): Niedre M J, Yu C S, Patterson M S, Wilson B C

Primary Institution: Ontario Cancer Institute/University Health Network

Hypothesis

The photobiological response in vivo is correlated with singlet oxygen generation, independent of individual treatment parameters.

Conclusion

The study found a strong correlation between singlet oxygen luminescence and the photodynamic therapy response in normal mouse skin.

Supporting Evidence

  • 1O2 luminescence was measured during treatment and correlated with skin response.
  • Significant variability in treatment response was observed between individual mice.
  • The study supports the hypothesis that singlet oxygen is the primary reactive oxygen species in photodynamic therapy.

Takeaway

This study shows that measuring a special light from singlet oxygen can help doctors know how well a treatment is working on skin.

Methodology

The study involved sensitizing hairless mice with amino-levulinic acid and measuring singlet oxygen luminescence during photodynamic therapy treatments.

Potential Biases

The skin scoring system used was somewhat subjective, which may introduce bias.

Limitations

Variability in treatment response was observed between individual mice, which may complicate predictions of treatment outcomes.

Participant Demographics

39 female hairless mice (SKH1-HR), aged 7–12 weeks.

Statistical Information

P-Value

0.005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602331

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication